Bioteck Symposium 20th ESSKA. The low molecular weight hydrolyzed collagen: a new infiltrative approach
Collagen is the main constituent of joints, tendons, ligaments. Thus, providing the “building blocks” of collagen to directly reinforce the extracellular matrix is the idea underneath CHondroGrid® medical device which is based on low molecular weight hydrolyzed collagen. In the lecture performed during the 20th ESSKA Congress the 27th of April 2022, the scientific background on the use of the low molecular weight hydrolyzed collagen for the pain relief and functional recovery of the cartilage, tendons and ligaments structures was presented. Moreover, the latest clinical results available for the treatment of Osteoarthrosis and tendinopathies in different anatomical districts with CHondroGrid® have been discussed.
